Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cambridge Antibody Technology Group -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (435)	1/3/2004 2:00:01 PM
From: keokalani'nui	Read Replies (2) \| Respond to of 625

If not to a jury at least to a judge. Plus, the same language/interpretation applies to the il-12 mab. Thus, for CAT, it's a fight to the death. I'm hoping for more than money, a torty claim or punishment--bad faith, intentional breach, intentional interference with expectancy (merger). I'm sure we don't know all of it, but if ABT's claim has as its only source the four corners of the license agreement they ought to be spanked hard. I feel, as they say in the west, the old west, ABT has crapped in its hat.